Medical Care Technologies Inc. Begins Development of Image Capture for Autism Using Tele-Health(TM) Suite
February 04 2010 - 3:11PM
Marketwired
Medical Care Technologies Inc. (OTCBB: MDCE) today announced the
initial development of Tele-Health™ Suite 6.17 technology with
image capture for Autism. This technology will allow families and
professionals to record behaviours and catalogue them within our
Medsuite™ for further analysis and treatment. Diagnosis relies on
behavioural observation and screening.
One of the most important child health issues gaining
international attention is the cluster of conditions known as
Autism Spectrum Disorder or ASD. It is also sometimes referred to
as Pervasive Developmental Disorder or PDD. The most available
information on autism focuses on children with the condition, even
though ASD persists when they become adults.
In 2007, the World Health Organization (WHO) argued that the
world faces a critical problem with the growing number of people
with mental and neurological problems, including autism, which
accounts for 11% of global disease. The number is projected to
reach 14.7% by 2020. Specifically for China, the WHO reported
1,100,000 cases of autism. George Hackworth's article, Autism and
Global Human Rights, reports that "the rate of autism is growing at
14% around the world, but in China it's growing at a rate of 20%
per year."
Ning Wu, President of Medical Care Technologies states, "The
importance of the Medical Care Technologies image capture
technology is to assist in early detection of symptoms. Early
symptom recognition and intervention can help the child function at
his or her highest possible level and it is our belief that early
detection of autistic symptomtology is key to better treatment
outcomes for autism in China."
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (www.medicaretech.com) is traded
under the symbol MDCE on the OTCBB and is based in London, England.
The Company is in the process of moving its portfolio of oil
resources into medical care technologies. The products/services
that the company hopes to acquire are intended to constitute a
healthcare delivery and wellness site, dedicated to helping Asian
consumers live healthier, more balanced lives. MDCE is planning to
provide advanced connectivity, internationally standardized and
secure business technology and information systems to assist the
Asian health industry -- physicians, pharmacists, medical
institutions, and consumers -- in accessing medical resources,
health services, education, wellness and pharmaceutical products
throughout Asia. MDCE is planning to distribute and provide
services at a diverse range of industry-leading product lines in
three segments: Medical Devices, Pharmaceuticals and
Nutraceuticals. Further information on the Company can be found at
www.sec.gov and the company's website at www.medicaretech.com
Safe Harbor Statement
All statements contained in this press release, other than
statements of historical fact, are forward-looking statements,
including those regarding: MDCE's products, services, capabilities,
performance, opportunities, development and business outlook,
guidance on our future financial results and other projections or
measures of our future performance; the amount and timing of the
benefits expected from strategic initiatives and acquisitions or
from deployment of new or updated technologies, products, services
or applications; and other potential sources of additional revenue.
These statements are based on our current plans and expectations
and involve risks and uncertainties that could cause actual future
events or results to be different than those described in or
implied by such forward-looking statements. These risks and
uncertainties include those relating to: lack of operating history,
transitioning from a development company to an operating company,
difficulties in distinguishing MDCE's products and services,
ability to deploy MDCE's services and products, market acceptance
of our products and services; operational difficulties relating to
combining acquired companies and businesses; our ability to form
and maintain mutually beneficial relationships with customers and
strategic partners; changes in economic, political or regulatory
conditions or other trends affecting the healthcare, Internet,
information technology and healthcare and pharmaceutical
industries, and our ability to attract and retain qualified
personnel. Other risks and uncertainties may include, but are not
limited to: lack of or delay in market acceptance and fluctuations
in customer demand, dependence on a limited number of significant
customers, reliance on third party vendors and strategic partners,
ability to meet future capital requirements on acceptable terms,
continuing uncertainty in the global economy, and compliance with
federal and state regulatory requirement. Further information about
these matters can be found in our Securities and Exchange
Commission filings. We expressly disclaim any intent or obligation
to update these forward-looking statements. There can be no
assurance that the acquisition of GUC's assets will close. MDCE
must issue 57,300,000 shares of its common stock to GUC, or GUC's
designees in order to close the acquisition. Accounting for the
anticipated cancellation of 57,300,000 shares by Patricia
Traczykowski, MDCE will have 98,900,000 shares of its common stock
issued and outstanding upon the closing of the acquisition.
For Further Information: Ezra Smith C. Jones Consulting, Inc.
Tel: (727) 771-9500 Fax: (727) 771-9545 Email:
cjones@cjonesconsulting.com Web: www.cjonesconsulting.com
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jul 2023 to Jul 2024